Probiotic-guided CAR-T cells for solid tumor targeting
Rosa L. Vincent(Columbia University), Tal Danino(Herbert Irving Comprehensive Cancer Center), Kenia de los Santos-Alexis(Columbia University), Andrew Redenti(Columbia University), Fangda Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Courtney Coker(Columbia University), Thomas Savage(Columbia University), Jongwon Im(Columbia University), Candice R. Gurbatri(Tempus Labs (United States)), Nicholas Arpaia(Columbia University Irving Medical Center), Edward R. Ballister(Columbia University), Meghna Komaranchath(Columbia University), Mathieu Rouanne(Université de Versailles Saint-Quentin-en-Yvelines), Ana Vardoshvili(Columbia University), Leonie Brockmann(Keio University)
Cited by 251
Related Papers
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
|Biology of Blood and Marrow Transplantation|2015|762
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
|Science Translational Medicine|2020|600
Engineering bacteria as interactive cancer therapies
|Science|2022|411